Xeris Biopharma Holdings, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
XERS Nasdaq 2830 www.xerispharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Xeris Biopharma Holdings, Inc.

Can Corcept Therapeutics Stock Rally 40% After This Dip? - Oct 26th, 2026 1:11 am
Xeris Biopharma to Report Third Quarter 2026 Financial Results and Business Highlights on November 5, 2026 - Oct 22nd, 2026 6:00 am
Xeris Biopharma Reinforces Leadership in Endocrinology With Data Disclosures Spanning Commercial Portfolio and Pipeline at Multiple Scientific Meetings - Oct 15th, 2026 6:00 am
Why Xeris Biopharma Holdings (XERS) Is Up 5.8% After Raising 2026 Revenue Guidance And Retiring Debt - Oct 8th, 2026 1:15 pm
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Oct 2nd, 2026 3:00 pm
Lundbeck approaches Xeris Biopharma over potential takeover, Bloomberg reports - Sep 29th, 2026 2:17 pm
Xeris Biopharma Reportedly Draws Takeover Interest — But Firm Says It’s ‘Not For Sale’ - Sep 29th, 2026 12:01 pm
Xeris Hosts Webinar Detailing Its Comprehensive Development Program for XP-8121, an Investigational, Once-Weekly Subcutaneous Levothyroxine for Hypothyroidism - Sep 9th, 2026 6:30 am
Xeris Announces Details for XP-8121 Program Overview Webinar - Aug 26th, 2026 5:30 am
Why Xeris Biopharma Holdings (XERS) Is Up 8.4% After Tightening 2026 Revenue Guidance And Advancing XP-8121 - Aug 15th, 2026 12:11 am
Xeris Biopharma Holdings (XERS) Posts Record Q2 Revenue, Is It Still A Bargain? - Aug 14th, 2026 1:10 pm
Xeris (XERS) Q2 2026 Earnings Call Transcript - Aug 13th, 2026 10:15 am
Xeris Biopharma Q2 Earnings Call Highlights - Aug 7th, 2026 2:04 pm
Xeris Biopharma Holdings Inc (XERS) (Q2 2026) Earnings Call Highlights: Record Revenue and ... - Aug 6th, 2026 5:13 pm
Compared to Estimates, Xeris Biopharma (XERS) Q2 Earnings: A Look at Key Metrics - Aug 6th, 2026 7:30 am
Xeris Biopharma Reports Second Quarter 2026 Financial Results - Aug 6th, 2026 5:00 am
Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026 - Jul 23rd, 2026 5:30 am
Xeris Biopharma (XERS) Moves 6.8% Higher: Will This Strength Last? - Jul 8th, 2026 8:37 am
CORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Jul 2nd, 2026 8:40 pm